v3.25.2
SHARE-BASED COMPENSATION
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
SHARE-BASED COMPENSATION

NOTE 13: SHARE-BASED COMPENSATION

 

Stock Options

 

During the years ended December 31, 2024 and 2023, the Company granted options for the purchase of the Company’s common stock to certain employees, consultants and advisors as consideration for services rendered. The terms of the stock option grants are determined by the Company’s Board of Directors. The Company’s stock options generally vest upon the one-year or two-year anniversary date of the grant and have a maximum term of ten years.

 

 

The following summarizes the stock option activity for the years ended December 31, 2024 and 2023:

SCHEDULE OF STOCK OPTION ACTIVITY 

   Options   Weighted-Average 
   Outstanding   Exercise Price 
Balance as of December 31, 2022   279   $775.93 
Grants   13,833    1,002 
Exercised   -    - 
Cancelled   -    - 
Balance as of December 31, 2023   14,112   $1.67 
Grants   850,775    1.24 
Exercised   -    - 
Cancelled   -    - 
Balance as of December 31, 2024   864,887   $1.25 

 

The weighted average grant date fair value of stock options granted during the years ended December 31, 2024 and 2023 was $1.24 and $15.12, respectively. The total fair value of stock options that granted during the year ended December 31, 2024 and 2023 was approximately $1,055,849 and $300,129, respectively. The fair value of each stock option is estimated on the date of grant using the Black-Scholes-Merton option pricing model with the following weighted average assumptions for stock options granted during the year ended December 31, 2024 and 2023:

SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS FOR STOCK OPTIONS GRANTED 

   2023   2022 
Expected term (years)   5    5 
Expected stock price volatility   %   220.36%
Weighted-average risk-free interest rate   %   4.169%
Expected dividend  $0.00   $0.00 

 

Volatility is a measure of the amount by which a financial variable such as share price has fluctuated (historical volatility) or is expected to fluctuate (expected volatility) during a period. The Company estimates expected volatility giving primary consideration to the historical volatility of its common stock. The risk-free interest rate is based on the published yield available on U.S. Treasury issues with an equivalent term remaining equal to the expected life of the stock option. The expected lives of the stock options represent the estimated period of time until exercise or forfeiture and are based on the simplified method of using the mid-point between the vesting term and the original contractual term.

 

The following summarizes certain information about stock options vested and expected to vest as of December 31, 2024:

SCHEDULE OF STOCK OPTIONS VESTED AND EXPECTED TO VEST 

       Weighted-Average     
   Number of   Remaining Contractual Life   Weighted-Average 
   Options   (In Years)   Exercise Price 
Outstanding   864,887    9.4   $6.15 
Exercisable   22,509    6.15   $32.89 
Expected to vest   842,378    9.42   $1.54 

 

As of December 31, 2024 and 2023, there was $644,886 and $381,547, respectively, of total unrecognized compensation cost related to non-vested stock-based compensation arrangements which is expected to be recognized within the next year.

 

 

Restricted Stock Awards

 

During the years ended December 31, 2024 and 2023, the Company issued restricted stock awards for shares of common stock which have been reserved for the holders of the awards. Restricted stock awards were issued to certain consultants and advisors as consideration for services rendered. The terms of the restricted stock units are determined by the Company’s Board of Directors. The Company’s restricted stock shares generally vest over a period of one year and have a maximum term of ten years.

 

The following summarizes the restricted stock activity for the years ended December 31, 2024 and 2023:

SCHEDULE OF RESTRICTED STOCK ACTIVITY 

       Weighted-Average 
   Shares   Fair Value 
Balance as of December 31, 2022   538    639.22 
Shares of restricted stock granted   19,676    225,000 
Exercised   -    - 
Cancelled   -    - 
Balance as of December 31, 2023   20,214    225,639 
Shares of restricted stock granted   73,258    180,000 
Exercised   -    - 
Cancelled   88,184    360,000 
Balance as of December 31, 2024   5,288    314,361 

 

SCHEDULE OF RESTRICTED STOCK AWARD

Number of Restricted Stock Awards  December 31, 2024   December 31, 2023 
Vested   413,862    5,288 
Non-vested   -    14,926 

 

As of December 31, 2024 and 2023, there was $-0- of total unrecognized compensation cost related to non-vested stock-based compensation, which is expected to be recognized over the next year.